CCR5 and HIV infectious disease: Another small molecule NBD-556 was the first reported inhibitor against HIV-1 gp120 [109], however, instead of inhibiting the HIV-1 infection it turned out to be a gp120 agonist and lead to the establishment of HIV infection in CD4− CCR5+ cells [110,111].